We report the case of a recurrent carotid cavernous fistula (CCF) originating from a giant cerebral aneurysm (GCA) after placement of a covered stent. A 47-year-old woman presented with sudden onset of severe headache, and left-sided exophthalmos and ptosis. Cerebral angiography revealed a CCF caused by rupture of a GCA in the cavernous segment of the left internal carotid artery. Two covered stents were placed at the neck of the aneurysm. The neurological symptoms improved at first, but were aggravated in the 6 months following the treatment. Contrast agent endoleak was seen in the distal area of the stent. Even though additional treatments were attempted via an endovascular approach, the CCF could not be cured. However, after trapping the aneurysm using coils and performing superficial temporal artery-middle cerebral artery bypass, the neurological symptoms improved. In cases of recurrent CCF originating from a GCA after placement of a covered stent, it is possible to treat the CCF by endovascular trapping and surgical bypass.
INTRODUCTION
A carotid cavernous fistula (CCF) can be classified into direct or indirect types, or a combination of both.
The direct type mainly results from trauma or rupture of a cavernous internal carotid artery (ICA) aneurysm.
Cavernous ICA aneurysms account for 1.9-9.0% of intracranial aneurysms.
13) About 1.5-9.0% of cavernous ICA aneurysms are complicated by a direct CCF.
10)17)
Furthermore, aneurysmal CCFs account for about 20% of direct CCFs. 11) CCFs may produce a series of symptoms, including exophthalmos, conjunctival injection, bruit, and cranial nerve impairment. Moreover, drainage to the cortical veins may lead to intracranial hemorrhage, 17) which requires careful treatment. At present, the first-line approach to treat CCF involves selecting an endovascular approach. 6)9)11)17) Furthermore, covered stents are frequently used for treatment of direct CCFs. 12)16)20) However, the first treatment attempt is not always successful. In this situation, a second treatment attempt (i.e., repeat endovascular treatment, surgical treatment, or a combination of both) should be considered. 11)12) We report the case of a recurrent CCF originating from a giant cerebral aneurysm (GCA) after placement of a covered stent.
CASE REPORT
A 47-year-old woman presented with sudden severe headache, exophthalmos, and left-sided ptosis. The However, after 6 months, the chemosis became aggravated. Therefore, brain CT angiography was performed, which revealed recurrence of the giant aneurysm and venous reflux. Cerebral angiography also confirmed recurrence of the CCF with the GCA (Fig. 3) .
Second endovascular treatment
To locate the leakage point, several attempts of superselective angiography using an Echelon- to pack the aneurysm with coils, it remained insufficiently packed. We had to finish the procedure with occlusion of the superior ophthalmic vein. After the procedure, the patient complained of a severe headache. After 1 week, we noted low density in the left temporal lobe on brain CT, which was thought to reflect a venous infarction (Fig. 4) .
Final treatment
Ten days after the second endovascular treatment, a third endovascular treatment was performed. We at- P-Com channel, and via the inferior petrosal sinus, but these approaches failed. Hence, as part of a planned internal trapping, the area from the distal part of the covered stent to the ophthalmic artery was temporally occluded using a Scepter C dual-lumen balloon catheter. After the distal part of the covered stent to the ophthalmic artery was occluded using the Scepter C balloon, angiography revealed choroidal blush and disappearance of the CCF. We then immediately performed internal trapping using a coil. After trapping, angiography revealed complete occlusion of the ICA from the region proximal to the stent to the region distal to the ophthalmic artery, aneurysm, and CCF (Fig. 5 ). Directly afterwards, we performed a superficial temporal artery middle cerebral artery bypass.
Because of the small caliber of the parietal branch, a double-barrel bypass was performed. Thereafter, the patient's headache was relieved (Fig. 6 ). Although mild ptosis remained, the patient achieved a stable condition. During clinical follow-up for another 6 months, no neurological abnormality recurred. course, but the rupture risk of a GCA is significantly higher in patients without thrombi or calcification.
5)10)17)
In the case presented here, the GCA was not accompanied by thrombi or calcification.
In Clopidogrel acts as a P2Y12 receptor inhibitor.
Clopidogrel is activated in the body in two steps, and many factors, including genetic variation, influence these steps. Therefore, the degree of drug reaction may show individual differences. Insufficiency of P2Y12 receptor inhibition, despite usual doses, is defined as clopidogrel resistance or high on-clopidogrel platelet reactivity (HPR). 2) In HPR patients, there is a tendency for frequent stent-related thromboembolic events during percutaneous coronary intervention. Further studies on this issue are required.
CONCLUSION
In a case of CCF from GCA after placement of a covered stent, it was possible to treat the CCF using endovascular trapping and surgical bypass.
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